Affiliation: World Health Organization
- Quality care at the end of life in AfricaCecilia Sepulveda
Programme on Cancer Control, World Health Organization, Avenue Appia 20, CH-1211 Geneva 27, Switzerland
BMJ 327:209-13. 2003
- Desirable services and guidelines for the treatment and palliative care of HIV disease patients with cancer in Africa: a World Health Organization consultationCharles Olweny
St. Boniface General Hospital, Winnipeg, Canada
J Palliat Care 19:198-205. 2003
- Prevention, screening and treatment of colorectal cancer: a global and regional generalized cost effectiveness analysisGary M Ginsberg
Costs, Effectiveness, Expenditure and Priority Setting, World Health Organization, Geneva, Switzerland
Cost Eff Resour Alloc 8:2. 2010..CONCLUSIONS: From a cost-effectiveness standpoint, screening programmes should be expanded in developed regions and treatment programmes should be established for colorectal cancer in regions with low treatment coverage...
- Effective cervical cytology screening programmes in middle-income countries: the Chilean experienceCecilia Sepulveda
WHO Programme on Cancer Control, Geneva, Switzerland
Cancer Detect Prev 29:405-11. 2005..To demonstrate that an effective cervical cancer screening programme based on the Papanicolaou (Pap) smear can be organized in a middle-income country, such as Chile...
- Palliative Care: the World Health Organization's global perspectiveCecilia Sepulveda
Program on Cancer Control, World Health Organization, Geneva, Switzerland
J Pain Symptom Manage 24:91-6. 2002
- Screening, prevention and treatment of cervical cancer -- a global and regional generalized cost-effectiveness analysisGary Michael Ginsberg
World Health Organization, Health Systems Financing Department, Costs, Effectiveness, Expenditure and Priority Setting Unit, Geneva, Switzerland
Vaccine 27:6060-79. 2009..Treatment should also be increased where coverage is low...
- Prevalence of antiphospholipid and antiplatelet antibodies in human immunodeficiency virus (HIV)-infected Chilean patientsIvan Palomo
Department of Clinical Biochemistry and Immunohematology, Faculty of Health Sciences, University of Talca, Talca, Chile
J Clin Lab Anal 17:209-15. 2003..Of the HIV-infected patients, 22.2% presented aPL and 9.4% aPlt antibodies. In this study, the presence of aPL and aPlt antibodies was not associated with the development of thrombosis and/or thrombocytopenia...